UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Operating Expenses Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual operating expenses in 2023 was 17.89 Million TWD , up 13.83% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 34.24 Million TWD , down -91.04% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported a annual operating expenses of 100.3 Million TWD in annual operating expenses 2022, up 7.66% from previous year.
  • UnicoCell Biomed Co., Ltd. reported a annual operating expenses of 93.16 Million TWD in annual operating expenses 2021, down -18.05% from previous year.
  • UnicoCell Biomed Co., Ltd. reported a quarterly operating expenses of 34.41 Million TWD for 2024 Q1, up 8.03% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported a quarterly operating expenses of 31.85 Million TWD for 2023 Q3, up 32.84% from previous quarter.

Annual Operating Expenses Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Operating Expenses of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 17.89 Million TWD 13.83%
2022 100.3 Million TWD 7.66%
2021 93.16 Million TWD -18.05%
2020 113.69 Million TWD 0.15%
2019 113.52 Million TWD 0.0%

Peer Operating Expenses Comparison of UnicoCell Biomed Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Apex Biotechnology Corp. 389.4 Million TWD 95.404%
Sinphar Pharmaceutical Co.,Ltd. 807.86 Million TWD 97.785%
Panion & Bf Biotech Inc. 817.56 Million TWD 97.811%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 437.58 Million TWD 95.91%
GenMont Biotech Incorporation 204.2 Million TWD 91.236%
Abnova (Taiwan) Corporation 126.72 Million TWD 85.877%
Adimmune Corporation 1.13 Billion TWD 98.421%
Tanvex BioPharma, Inc. 2.16 Billion TWD 99.172%
Polaris Group -3.06 Million TWD 683.915%
Energenesis Biomedical CO.,LTD. 267.06 Million TWD 93.299%
PELL Bio-Med Technology Co. Ltd. 385.1 Million TWD 95.353%